Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia
Clinical trial NCT06176235 · WITHDRAWN
Trial details
- NCT number
- NCT06176235
- Sponsor
- Peking University People's Hospital
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-19
- Primary completion
- 2024-12-12
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.